Is 2-(3-(Trifluoromethyl)anilino)nicotinic acid Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 2-(3-(Trifluoromethyl)anilino)nicotinic acid? Is 2-(3-(Trifluoromethyl)anilino)nicotinic acid safe for nursing mother and child? Does 2-(3-(Trifluoromethyl)anilino)nicotinic acid extracts into breast milk? Does 2-(3-(Trifluoromethyl)anilino)nicotinic acid has any long term or short term side effects on infants? Can 2-(3-(Trifluoromethyl)anilino)nicotinic acid influence milk supply or can 2-(3-(Trifluoromethyl)anilino)nicotinic acid decrease milk supply in lactating mothers?
2-(3-(Trifluoromethyl)anilino)nicotinic acid lactation summary
- DrLact safety Score for 2-(3-(Trifluoromethyl)anilino)nicotinic acid is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of 2-(3-(Trifluoromethyl)anilino)nicotinic acid may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that 2-(3-(Trifluoromethyl)anilino)nicotinic acid may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of 2-(3-(Trifluoromethyl)anilino)nicotinic acid low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using 2-(3-(Trifluoromethyl)anilino)nicotinic acid We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 2-(3-(Trifluoromethyl)anilino)nicotinic acid usage in lactation
Active metabolite of Morniflumate. At latest update, relevant information on excretion into breast milk was not found. Due to a high serum-protein-binding capacity, excretion of Rabeprazole into breast milk in significant levels is unlikely. Based on data offered by the manufacturer, excretion into breast milk is minimal, with a concentration in the milk which is one-hundredth less than plasma level. Nevertheless, it would be prudent the use of anti-inflammatory drugs known to be safe while breastfeeding.
Alternate Drugs for Antiinflammatory and antirheumatic products, non-steroids and others specific. ATC M01A-C
Auranofin(Low Risk)
Celecoxib(Safe)
Diclofenac(Safe)
Etodolac(Low Risk)
Fenoprofen(Safe)
Flurbiprofen(Safe)
Ibuprofen(Safe)
Indomethacin(Safe)
Ketorolac(Safe)
Meclofenamate(Low Risk)
Mefenamic Acid(Safe)
Meloxicam(Low Risk)
Nabumetone(Low Risk)
Naproxen(Low Risk)
Penicillamine(Low Risk)
Piroxicam(Safe)
Sulindac(Low Risk)
Tolmetin(Safe)
Oxaprozin(Low Risk)
Ketoprofen(Safe)
Glucosamine(Safe)
Apazone(Safe)
Niflumic Acid(Low Risk)
Nimesulide(Unsafe)
Parecoxib(Low Risk)
Proglumetacin(Unsafe)
Rofecoxib(Unsafe)
Azapropazone(Safe)
Aceclofenac(Safe)
Aurothiomalate Sodium(Low Risk)
Clonixin(Low Risk)
Dexibuprofen(Safe)
Dexketoprofen(Safe)
Diacerein(Low Risk)
Etoricoxib(Low Risk)
Phenylbutazone(Safe)
Lornoxicam(Low Risk)
Loxoprofen(Low Risk)
Meclofenamic Acid(Low Risk)
Diclofenac Potassium(Safe)
Diclofenac Sodium(Safe)
Chitosamine(Safe)
Azapropazon(Safe)
Ibuprofen Lysine(Safe)
Etodolic Acid(Low Risk)
Indometacin(Safe)
Indomethacin Sodium(Safe)
Butadione(Safe)